Biotechnology company Zealand Pharma A/S (CPH:ZEAL)(NYSE:ZEAL) on Friday announced that it has appointed Ivan Møller to the new position of senior vice president, Technical Development & Operations, effective 1 March 2018.
Most recently, Møller held senior management positions at Novartis in both generics and pharmaceutical manufacturing, as well as strategy, quality assurance, contract manufacturing and supply chain leadership in Germany, the US and Switzerland.
Prior to joining Novartis, Møller was project leader at The Boston Consulting Group in New York, NY where he led client engagements in the pharmaceutical R&D and manufacturing areas. He started his career at PolyPeptide Laboratories where he was head of Production site.
Zealand Pharma is focused on the discovery, design and development of innovative peptide-based medicines. It has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim, as well as a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
Nephron Pharmaceutical names new chief procurement officer
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US